|
Post application efficacy intervals
|
Group A
|
Group B
|
Group C
|
Group D
|
p value
|
|---|
|
Immediate
|
0.002π
|
|
(Mean scores ± SD)
|
5.10 ± 1.88
|
4.20 ± 1.70
|
4.65 ± 1.87
|
5.65 ± 1.49
|
|
(p value)ψ
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
|
Day 3
|
0.110π
|
|
(Mean scores ± SD)
|
4.90 ± 1.48
|
3.15 ± 1.95
|
3.90 ± 2.31
|
5.55 ± 1.46
|
|
(p value)ψ
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
|
Week 2
|
0.002π
|
|
(Mean scores ± SD)
|
3.45 ± 1.84
|
3.10 ± 2.19
|
3.60 ± 2.25
|
5.45 ± 1.57
|
|
(p value)ψ
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
|
Week 4
|
0.001π
|
|
(Mean scores ± SD)
|
2.90 ± 2.07
|
2.45 ± 2.16
|
3.10 ± 2.19
|
5.00 ± 1.68
|
|
(p value)ψ
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
|
Week 6
|
0.001π
|
|
(Mean scores ± SD)
|
2.35 ± 2.00
|
2.15 ± 1.92
|
3.05 ± 2.04
|
4.55 ± 1.95
|
|
(p value)ψ
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
|
(p value)ω
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
| |
- Group A received BioMin® F. Group B received Colgate Sensitive Pro relief™. Group C received Sensodyne Rapid Action™. Group D received Colgate Total™
- SD standard deviation
- ψWilcoxon Signed-Rank Test; πKruskal–Wallis test; ωFriedman test; p values were considered significant at 0.05
